Los Angeles Times | May 24, 2022
“This is a very good vaccine, but the FDA has slow-walked it every step of the way,” said Lawrence Gostin, an expert in public health law expert at Georgetown University.
Los Angeles Times | May 24, 2022
“This is a very good vaccine, but the FDA has slow-walked it every step of the way,” said Lawrence Gostin, an expert in public health law expert at Georgetown University.
Press Release
September 27, 2023
In The News
September 25, 2023
In The News
September 25, 2023